AMRI
Albany Molecular Research, Inc. (AMRI) and Codexis have entered into a SMARTSOURCING partnership. The collaboration will provide opportunities to combine the two companies’ capabilities and technologies for specific customer projects, yielding increased value to customers in the form of potentially lower costs, greater yields, cleaner processes and/or faster turnaround times.
Under this non-exclusive, two-year agreement, the companies will align their respective strengths to identify and implement new and improved manufacturing routes for selected APIs. Combining Codexis’ directed evolution technology that enables rapid enzyme discovery and optimisation with AMRI’s process development and manufacturing capabilities, including utilising AMRI’s proprietary microbial strains, creates synergies that will broaden both companies’ ability to offer customers cost-effective, efficient and sustainable manufacturing processes.
“We are pleased to announce this partnership with Codexis, a company that shares our philosophy of prioritising scientific problem solving, innovation and customer service,” said AMRI’s Chairman, President and CEO, Thomas E. D’Ambra, Ph.D. “Combining AMRI’s expertise in chemistry, biocatalysis, quality assurance and manufacturing with Codexis’ cutting-edge biocatalysis technology and services creates a proprietary advantage to our customers’ development projects. This is another example of the AMRI SMARTSOURCING strategy of creating partnerships to deliver better outcomes to our customers.”
“Codexis selected AMRI for this collaboration because AMRI understands the opportunity to use biocatalysis for effective and comprehensive route assessment and manufacturing,” said Dr. Peter Seufer-Wasserthal, SVP Pharmaceuticals, Codexis. “Both companies have established strong reputations in the pharmaceutical manufacturing industry. By working together, AMRI and Codexis should identify more opportunities, which will benefit both companies and their customers by developing innovative, cost-effective and practical chemical processes.”
Albany Molecular Research, Inc., +1 518 512 2261, www.amriglobal.com.
Codexis, Inc., +1 212 362 1200, www.codexis.com.